Skip to content

Effectiveness of an interactive web-based platform and a disease specific information website in patients with heart failure: a 3-arm randomised trial.

Effectiveness of an interactive web-based platform and a disease specific information website in patients with heart failure: a 3-arm randomised trial. - E-Vita heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40041
Enrollment
414
Registered
2013-03-07
Start date
2013-09-16
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congestive cardiac failure Heart failure

Interventions

Arm 1. Usual care
2. Disease specific educational website (in addition to usual care). This website is the very recently completed Dutch translation of the European informative website about HF developed by the Heart

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - HF established according to the guidelines of the European Society of Cardiology (ESC), and confirmed with echocardiography at least three months ago. - Sufficient cognitive and physical function to understand the aim of the study and perform or undergo the required measurements and sign informed consent. - Aged 18 years or over.

Exclusion criteria

Exclusion criteria: - Non-availability of internet and email. - Inability to work with internet and e-mail. - Inability of the patient and his/her family or care takers to read and understand Dutch.

Design outcomes

Primary

MeasureTime frame
The primary outcomes are self care behaviour and quality of life measured with the validated European Heart Failure Self Care Behaviour Scale (EHFScB scale) and the short-form health survey with 36 questions (SF36), EuroQol 5 Dimensions (EQ-5D), and Minnesota Living with Heart Failure Questionnaire (MLHFQ) respectively.

Secondary

MeasureTime frame
Secondary outcome are all-cause mortality, HF related hospitalisations, duration of HF related hospitalisations and disease specific knowledge measured with the Dutch Heart Failure knowledge scale, heart function and evaluation of use of website measured with the *use of website* and website user satisfaction (WUS) questionnaire. A cost-effectiveness analysis will be part of the study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)